News & Analysis
/
Article

Computational analysis pipeline accurately identifies schizophrenia and bipolar disorder in tissue cultures

SEP 26, 2025
Building on previous data studying organoids derived from patients with neuropsychiatric disorders, this computational model can differentiate between signals
Hannah Daniel Headshot.jpg
Media Relations Specialist

DOI: 10.1063/10.0039495

Computational analysis pipeline accurately identifies schizophrenia and bipolar disorder in tissue cultures internal name

Computational analysis pipeline accurately identifies schizophrenia and bipolar disorder in tissue cultures lead image

Diagnosing neuropsychiatric disorders like schizophrenia (SCZ) and bipolar disorder (BD) can be difficult, as diagnostic criteria can differ even between doctors. In previous research, author Annie Kathuria tested lab-grown tissue cultures — known as organoids — for electrical signals related to psychiatric diseases, and in new research, Cheng et al. used that data to create a computational model to identify SCZ and BD.

“The beauty of an induced pluripotent stem cell is that it carries a person’s genetics,” Kathuria said. “So, if there are cells taken from a schizophrenic patient, we would expect the organoid to show [the same biological] characteristics.”

Because there are no clear genetic markers for diseases, electrical signals from multi-electrode arrays (MEA), which are like electroencephalograms for organoids, can be processed and used for identifying SCZ and BD.

“What our MEA machines can do is record the electrical activity of an organoid placed on top of them, and we can also stimulate the organoid using electrical pulses,” Kathuria said.

Their computational analysis pipeline was created with a support vector machine classifier — a machine learning algorithm — optimized for high-dimensional data. The pipeline was able to differentiate BD and SCZ from control organoids with 83.3% accuracy, and that number improved to 91.6% in the signals from the organoids that experienced electrical stimulation.

Beyond increasing the organoid number by expanding the donor cohort, Kathuria imagines their research will be used for drug development. By creating organoids from a patient’s stem cells, researchers will be able to test a drug’s efficacy on an organoid rather than a person.

Source: “Machine learning–enabled detection of electrophysiological signatures in iPSC-derived models of schizophrenia and bipolar disorder,” by Kai Cheng, Autumn Williams, Anannya Kshirsagar, Sai Kulkarni, Rakesh Karmacharya, Deok-Ho Kim, Sridevi V. Sarma, and Annie Kathuria, APL Bioengineering (2025). The article can be accessed at https://doi.org/10.1063/5.0250559 .

This paper is part of the Bioengineering of the Brain Collection, learn more here .

More Science
AAS
/
Article
APS
/
Article
/
Article
Artificial intelligence and parallel computing could refine studies of the movement of single molecules inside cells.
/
Article
Integration and fusion of data will add more autonomy, efficiency, and speed.
/
Article
Dual-frequency photo-sono therapy improves the precision and ultrasonic threshold of cavitation-based treatment
/
Article
An extrapolation technique aims to address the gap between Hall effect thruster performance in space and in laboratory conditions.